Theradiag: THERADIAG notes the acquisition of a stake in its capital by BIOSYNEX

Regulatory News: THERADIAG (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and Theranostics, today announces that it has received yesterday a letter

Related Keywords

Marne ,Schleswig Holstein ,Germany ,Paris ,France General ,France ,French ,Pierre Laurent ,Financial Communications Investor Relations ,Regulatory News ,Rights Issue ,Euronext Growth Paris ,Managing Director ,Communications Investor Relations ,Theradiag ,Votes ,Cquisition ,Stake ,Capital ,Biosynex ,